Myasthenia gravis-like Myopathy in metastatic cutaneous Squamous Cell Carcinoma under Anti-PD-1 Therapy

被引：0
|
作者：
Koett, J. [1 ]
Christolouka, M. [1 ]
Haalck, T. [1 ]
Schneider, S. W. [1 ]
Gebhardt, C. [1 ]
机构：
[1] Univ Hamburg Eppendorf, Dermatol & Venerol, Hamburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2020年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P113
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [21] ANTI-EGFR ANTIBODY ADDED TO ONGOING ANTI-PD-1 ANTIBODY TREATMENT FOR METASTATIC CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE FACE: TWO CASE REPORTS
    Eton, Omar
    Hsu, Emily
    Patel, Akshay
    Eton, Omar
    Cartun, Richard
    Earle, Jonathan
    Mnayer, Laila
    Yu, Peter
    Kotowitz, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A284 - A286
  • [22] Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma
    Hanna, Glenn J.
    Oakley, L. B.
    Shi, R.
    Oneill, A.
    Shin, K. Y.
    Scarfo, N.
    Sehgal, K.
    Dennis, M. J.
    Quinn, N.
    Jo, V. Y.
    Wong, K.
    Shvyrkova, A.
    Kushnarev, V.
    Shanthappa, B. U.
    Tkachuk, A.
    Kryukov, K.
    Sarachakov, A.
    Svekolkin, V.
    Lennerz, J.
    Waters, S.
    Haddad, R. I.
    CLINICAL CANCER RESEARCH, 2025, 31 (04) : 619 - 627
  • [23] Duvelisib with docetaxel for patients with anti-PD-1 refractory, recurrent, or metastatic head and neck squamous cell carcinoma
    Hanna, Glenn J.
    Oakley, Liam B.
    Shi, Ruichao
    ONeill, Anne
    Shin, Kee-Young
    Sehgal, Kartik
    Dennis, Michael J.
    Jo, Vickie Y.
    Wong, Kristine S.
    Haddad, Robert I.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Combination of anti-PD-1 inhibitors with radiotherapy for recurrent/metastatic squamous cell carcinoma in the head and neck region
    Tamaskovics, Balint
    Haussmann, Jan
    Neuwahl, Judith
    Jazmati, Danny
    Plettenberg, Christian
    Althaus, Laurenz
    Boelke, Edwin
    Matuschek, Christiane
    Budach, Wilfried
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S166 - S166
  • [25] A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma
    Y. Cai
    Fei Wang
    Q. Liu
    Z. Li
    D. Li
    Z. Sun
    Investigational New Drugs, 2019, 37 : 799 - 809
  • [26] A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma
    Cai, Y.
    Wang, Fei
    Liu, Q.
    Li, Z.
    Li, D.
    Sun, Z.
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (05) : 799 - 809
  • [27] The efficacy of subsequent therapy after failure of anti-PD-1 antibody in metastatic renal cell carcinoma
    Zhou, Yu
    Ma, Baozhen
    Gao, Quanli
    Zhao, Lingdi
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (05) : 2238 - 2250
  • [28] Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder
    Chang, Elaine
    Sabichi, Anita L.
    Sada, Yvonne H.
    JOURNAL OF IMMUNOTHERAPY, 2017, 40 (03) : 114 - 116
  • [29] Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma
    Yochum, Zachary A.
    Braun, David
    LANCET, 2024, 404 (10460): : 1280 - 1282
  • [30] Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey
    Samaran, Quentin
    Samaran, Romain
    Ferreira, Ernestine
    Haddad, Naeda
    Fottorino, Antoine
    Maillard, Herve
    Dreno, Brigitte
    Meyer, Nicolas
    Azria, David
    Maubec, Eve
    Gaudy-Marqueste, Caroline
    Molinari, Nicolas
    Stoebner, Pierre-Emmanuel
    Dereure, Olivier
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3549 - 3562
12345